Ischaemic stroke is responsible for substantial death and disability and creates a huge financial burden for healthcare budgets worldwide. At present there are few effective treatments for acute stroke and these are urgently required. Increased understanding of the ischaemic cascade has generated interest in neuroprotection for focal cerebral ischaemia. However, treatment effects observed in of over 500 interventions in animal models have yet to be translated to the clinic. Systematic review and meta-analysis allows unbiased identification of all relevant data for a given intervention, gives a clearer view of its true efficacy and the limitations to its therapeutic potential. Understanding the reasons for this bench-to-bedside failu...
Background:Amplifying endogenous neuroprotective mechanisms is a promising avenue for stroke therapy...
IMPORTANCE: Preclinical stroke research has had a remarkably low translational success rate, and the...
BACKGROUND AND PURPOSE: Numerous neuroprotective agents have proven effective in animal stroke studi...
Background: There are numerous potential treatments assessed for acute cerebral ischemia using anima...
Animal models of ischaemic stroke have become an integral part of the preclinical pipeline for ident...
Background and Purpose—The extensive neuroprotective literature describing the efficacy of candidate...
Background and Purpose-The neutral results of the SAINT II trial have again highlighted difficulties...
FK506 is a candidate drug for acute stroke. For such drugs, any decision to proceed to clinical tria...
As a research community, we have failed to demonstrate that drugs that show substantial efficacy in ...
Background and Purpose - At least part of the failure in the transition from experimental to clinica...
To assess the true effect of novel therapies for ischaemic stroke, a positive control that can valid...
The consolidation of scientific knowledge proceeds through the interpretation and then distillation ...
Low translational yield for stroke may reflect the focus of discovery science on rodents rather than...
Despite testing more than 1,026 therapeutic strategies in models of ischemic stroke and 114 therapie...
Ischaemic stroke is a leading cause of death and long-lasting disability. Several neuroprotective dr...
Background:Amplifying endogenous neuroprotective mechanisms is a promising avenue for stroke therapy...
IMPORTANCE: Preclinical stroke research has had a remarkably low translational success rate, and the...
BACKGROUND AND PURPOSE: Numerous neuroprotective agents have proven effective in animal stroke studi...
Background: There are numerous potential treatments assessed for acute cerebral ischemia using anima...
Animal models of ischaemic stroke have become an integral part of the preclinical pipeline for ident...
Background and Purpose—The extensive neuroprotective literature describing the efficacy of candidate...
Background and Purpose-The neutral results of the SAINT II trial have again highlighted difficulties...
FK506 is a candidate drug for acute stroke. For such drugs, any decision to proceed to clinical tria...
As a research community, we have failed to demonstrate that drugs that show substantial efficacy in ...
Background and Purpose - At least part of the failure in the transition from experimental to clinica...
To assess the true effect of novel therapies for ischaemic stroke, a positive control that can valid...
The consolidation of scientific knowledge proceeds through the interpretation and then distillation ...
Low translational yield for stroke may reflect the focus of discovery science on rodents rather than...
Despite testing more than 1,026 therapeutic strategies in models of ischemic stroke and 114 therapie...
Ischaemic stroke is a leading cause of death and long-lasting disability. Several neuroprotective dr...
Background:Amplifying endogenous neuroprotective mechanisms is a promising avenue for stroke therapy...
IMPORTANCE: Preclinical stroke research has had a remarkably low translational success rate, and the...
BACKGROUND AND PURPOSE: Numerous neuroprotective agents have proven effective in animal stroke studi...